Girolamo Alfieri

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

James F. Howard, Vera Bril, Tuan Vu et al. · The Lancet Neurology · 2021 · 587 citations · Full text

Medicine, Generalised Myasthenia Gravis

Muscle MRI in immune-mediated necrotizing myopathy (IMNM): implications for clinical management and treatment strategies

Laura Fionda, Antonio Lauletta, Luca Leonardi et al. · Journal of Neurology · 2022 · 24 citations · Full text

Muscle magnetic resonance imaging in myotonic dystrophy type 1 (DM1): Refining muscle involvement and implications for clinical trials

Matteo Garibaldi, Tommaso Nicoletti, Elisabetta Bucci et al. · European Journal of Neurology · 2021 · 20 citations · Full text

Longitudinal study of a cohort of MSA-C patients in South Italy: survival and clinical features

Maria Lieto, Alessandro Roca, Dario Bruzzese et al. · Neurological Sciences · 2019 · 19 citations

Clinical Epidemiology, Msa-c Patients, Public Health +3

Changes of clinical, neurophysiological and nerve ultrasound characteristics in CIDP over time: a 3-year follow-up

Laura Fionda, Antonella Di Pasquale, Stefania Morino et al. · Journal of Neurology · 2021 · 16 citations

Neurophysiology, Physiology, 3-Year Follow-up +8